Navigation Links
DURECT Corporation Presenting at the 2008 UBS Global Generic and Specialty Pharmaceuticals Conference
Date:5/21/2008

CUPERTINO, Calif., May 21 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that it will present at the 2008 UBS Global Generic and Specialty Pharmaceuticals Conference being held at the Waldorf Hilton Hotel in London. Matthew J. Hogan, Chief Financial Officer, will be presenting at the conference on May 28th at 4:00 p.m. British Time / 11:00 a.m. Eastern Time.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO)

A live audio webcast of the presentation will be available by accessing DURECT's homepage at http://www.durect.com and clicking "Investor Relations." If you are unable to participate during the live webcast, the call will be archived on DURECT's website under Audio Archive in the "Investor Relations" section.

About DURECT Corporation

DURECT Corporation is an emerging specialty pharmaceutical company developing pharmaceutical systems based on its proprietary drug delivery platform technologies. The Company currently has a number of late-stage pharmaceutical products in development addressing large markets in pain management, with a number of research programs underway targeting chronic disease and other therapeutic areas. For more information, please visit http://www.durect.com.


'/>"/>
SOURCE DURECT Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. DURECT Corporation Invites You to Join Its First Quarter 2008 Earnings Conference Call
2. DURECT to Participate in Morgan Stanley Global Healthcare Conference
3. DURECT Provides Update on CHRONOGESIC(R) Research Program
4. DURECT to Participate in Cowen Annual Healthcare Conference
5. DURECT to Participate in Susquehanna Financial Healthcare Conference
6. DURECT to Present at BIO CEO Investor Conference 2008
7. DURECT to Present at 2007 BIO Investor Forum
8. DURECT to Present at UBS Global Life Sciences Conference
9. DURECT to Present at Merriman Curhan Fords Annual Investor Summit
10. Conseco Shareholders Re-Elect 10 Directors, Approve Two Amendments To Certificate Of Incorporation And Ratify Independent Registered Public Accounting Firm
11. Volcano Corporation Presentation at JMP Conference to be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Steven Reinberg HealthDay ... People who have dementia and heart rhythm irregularities are more ... research has found. In fact, the study of more ... to 80 percent more likely to get a pacemaker than ... from this study is why folks with dementia are so ...
(Date:7/28/2014)... 2014 Parker Waichman LLP, a personal injury ... that the heroes of 9/11 are never forgotten, comments that ... important deadline. According to a VCF message dated ... cancer on or before October 12, 2012 must file a ... and others who were allegedly injured by the toxic dust ...
(Date:7/28/2014)... the meal you,ve ordered at a restaurantor when ... through your brain. , These waves are ... of cellsboth excitatory and inhibitoryplaying together in an ... gamma waves have been associated with higher-level brain ... tied to schizophrenia, Alzheimer,s disease, autism, epilepsy and ...
(Date:7/28/2014)... two dopamine-producing regions in the brain was able to ... propofol. In the August issue of Anesthesiology ... rats anesthetized with continuous doses of either agent would ... response to electrical stimulation delivered to the ventral tegmental ... area, the substantia nigra, did not induce the animals ...
(Date:7/28/2014)... Lourdes Health System has partnered with a ... times for veterans needing medical care. , Lourdes is ... the only one in Camden, Burlington and Gloucester counties—participating ... (PC3). PC3 gives veterans access to specialty care when ... due to lack of available specialists, long wait times ...
Breaking Medicine News(10 mins):Health News:Pacemakers Common for Those With Dementia and Irregular Heartbeats 2Health News:Pacemakers Common for Those With Dementia and Irregular Heartbeats 3Health News:October 12, 2014 Deadline Approaching for 9/11 First Responders Suffering from Certain Cancers to Submit Their Registration to the VCF, Parker Waichman LLP Comments 2Health News:October 12, 2014 Deadline Approaching for 9/11 First Responders Suffering from Certain Cancers to Submit Their Registration to the VCF, Parker Waichman LLP Comments 3Health News:Memory relies on astrocytes, the brain's lesser known cells 2Health News:Memory relies on astrocytes, the brain's lesser known cells 3Health News:Stimulation of brain region restores consciousness to animals under general anesthesia 2Health News:Lourdes Expands Military Partnership with Veterans 2Health News:Lourdes Expands Military Partnership with Veterans 3
... Research Laboratories of the Catholic University of Campobasso (Italy) ... has on our health. But this time it is ... drinking in moderation reduces all-cause mortality. ... Internal Medicine, assembled 34 scientific studies conducted during the ...
... and Michael Robinson (Ohio State University) and colleagues uncover ... gene// , Rb, in the developing mammalian embryo. ... in Rb die as embryos. Using a combination of ... have now determined why: Rb is required for the ...
... the journal SLEEP, sleep-disturbed children are more severely depressed ... compared with children without sleep disturbance. ... children are advised to first consult with the child's ... specialist for comprehensive testing and treatment. ,The ...
... Musculoskeletal and Skin Diseases (NIAMS), part of the National ... the University of Virginia// in Charlottesville have succeeded in ... ,A team of researchers led by NIAMS’ ... seasonal H3N2 strain of influenza A virus, has been ...
... human puberty also appears to control reproductive activity ... and// University of California at Berkeley scientists in ... accessible online via the journal's rapid electronic publication ... kisspeptin, a recently discovered neuropeptide encoded by the ...
... the production of a critical blood-clotting protein. Treatments for ... may consist of risky blood transfusions or expensive enzyme ... induced to begin producing these proteins, say by transplanting ... ,Prof. Yair Reisner and Ph.D. student Anna Aronovich of ...
Cached Medicine News:Health News:Alcohol in Moderation Could Increase the Life Span 2Health News:Alcohol in Moderation Could Increase the Life Span 3Health News:Link Between Insomnia and Hypersomnia, Depression in Children 2Health News:Molecular Anatomy of Influenza Virus Detailed 2Health News:Sex Ends as Seasons Shift and Kisspeptin Levels Plummet 2Health News:Sex Ends as Seasons Shift and Kisspeptin Levels Plummet 3Health News:A Transplant in Time - Scientists ID Window for Tissue Transplant 2
(Date:7/28/2014)... 28, 2014 Concord Medical Services Holdings Limited ... ), a leading specialty hospital management solution provider and ... imaging centers in China , today ... Directors declared a special cash dividend of US$0.30 per ... on the Company,s outstanding ordinary shares. The total expense ...
(Date:7/28/2014)... CHAPEL HILL, N.C. , July 28, 2014 /PRNewswire/ ... results of a clinical trial demonstrating that CXL-1427, a ... was well tolerated in healthy volunteers. The company has ... failure in a Phase IIa clinical trial designed to ... as its dosing levels. The Phase I ...
(Date:7/28/2014)... CARLSBAD, Calif. , July 28, 2014  Isis ... following webcast:What:Isis Pharmaceuticals, Second Quarter 2014 Financial Results and ... / 7:30 a.m. PTWhere: www.isispharm.com How:Live on the ... you are unable to participate during the live event, ... a limited time at www.isispharm.com . ...
Breaking Medicine Technology:Concord Medical Declares Special Dividend 2Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 2Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 2
... 2012  Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, ... 2012, at 8:30 AM ET, to discuss its financial ... to issue its quarterly financial results press release before ... To participate in the live conference call, please dial ...
... 2012 Young Innovations, Inc. (NASDAQ: YDNT ) today ... 31, 2012.  Sales for the first quarter of ... reported in the first quarter of 2011. Income from operations increased ... $5.8 million in the first quarter of 2011. Net income increased ...
Cached Medicine Technology:Insmed to Host 2012 First Quarter Earnings Conference Call 2Insmed to Host 2012 First Quarter Earnings Conference Call 3Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012 2Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012 3Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: